Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Suicidal ideation among children taking atomoxetine (Strattera).

Wooltorton E.

CMAJ. 2005 Dec 6;173(12):1447. No abstract available.

2.

Warning on Strattera for attention-deficit hyperactivity disorder.

[No authors listed]

FDA Consum. 2005 Nov-Dec;39(6):4. No abstract available.

3.

[Atomoxetine--Strattera. Oral preparation].

Duh PD, Macken E.

J Pharm Belg. 2006;61(4):117-20. French. No abstract available.

PMID:
17263193
4.

Acute suicidality after commencing atomoxetine.

Paxton GA, Cranswick NE.

J Paediatr Child Health. 2008 Oct;44(10):596-8. doi: 10.1111/j.1440-1754.2008.01389.x.

PMID:
19012633
5.

Meta-analysis of suicide-related behavior events in patients treated with atomoxetine.

Bangs ME, Tauscher-Wisniewski S, Polzer J, Zhang S, Acharya N, Desaiah D, Trzepacz PT, Allen AJ.

J Am Acad Child Adolesc Psychiatry. 2008 Feb;47(2):209-18. doi: 10.1097/chi.0b013e31815d88b2.

PMID:
18176331
6.

Does atomoxetine increase the risk of aggression and hostility in children with attention deficit hyperactivity disorder?

Banerjee S, Ayyash HF.

Arch Dis Child Educ Pract Ed. 2008 Aug;93(4):131-2. doi: 10.1136/adc.2008.142356. No abstract available. Erratum in: Arch Dis Child Educ Pract Ed. 2010 Dec;95(12):1071.

PMID:
18644903
7.

Atomoxetine-induced electrocardiogram changes.

Rajesh AS, Bates G, Wright JG.

Arch Dis Child. 2006 Dec;91(12):1023-4. No abstract available.

8.

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.

Bangs ME, Hazell P, Danckaerts M, Hoare P, Coghill DR, Wehmeier PM, Williams DW, Moore RJ, Levine L; Atomoxetine ADHD/ODD Study Group.

Pediatrics. 2008 Feb;121(2):e314-20. doi: 10.1542/peds.2006-1880. Erratum in: Pediatrics.2008 Jul;122(1): 227.

PMID:
18245404
9.

Increased blood pressure and atomoxetine.

Dworkin N.

J Am Acad Child Adolesc Psychiatry. 2005 Jun;44(6):510. No abstract available.

PMID:
15908831
10.

Atomoxetine-induced hyponatremia.

Singh T.

Aust N Z J Psychiatry. 2007 May;41(5):458. No abstract available.

PMID:
17464740
11.

First case of sialolithiasis associated with atomoxetine.

Jerome L, Gardner D, Kutcher SP.

J Clin Psychopharmacol. 2007 Feb;27(1):111-2. No abstract available.

PMID:
17224735
12.

Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression.

Atomoxetine ADHD and Comorbid MDD Study Group, Bangs ME, Emslie GJ, Spencer TJ, Ramsey JL, Carlson C, Bartky EJ, Busner J, Duesenberg DA, Harshawat P, Kaplan SL, Quintana H, Allen AJ, Sumner CR.

J Child Adolesc Psychopharmacol. 2007 Aug;17(4):407-20.

PMID:
17822337
13.

Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?

Niederhofer H.

Psychiatr Danub. 2009 Sep;21(3):330. No abstract available.

14.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
15.

Postmortem tissue distribution of atomoxetine following fatal and nonfatal doses--three case reports.

Garside D, Ropero-Miller JD, Riemer EC.

J Forensic Sci. 2006 Jan;51(1):179-82.

PMID:
16423247
16.

Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine.

Wernicke JF, Holdridge KC, Jin L, Edison T, Zhang S, Bangs ME, Allen AJ, Ball S, Dunn D.

Dev Med Child Neurol. 2007 Jul;49(7):498-502.

18.

[My child is so restless].

Schlamp D.

MMW Fortschr Med. 2007 Mar 8;149(10):39-40. Review. German.

PMID:
17408047
19.

Persistent camptocormia associated with atomoxetine in a child with attention-deficit/hyperactivity disorder.

Bhattacharya A, Praharaj SK, Sinha VK.

J Child Adolesc Psychopharmacol. 2014 Dec;24(10):596-7. doi: 10.1089/cap.2014.0059. No abstract available.

PMID:
25469421
20.

Atomoxetine-induced myocardial infarction.

Seifi A, Griffith H, Avestimehr S, Dib H.

South Med J. 2011 Feb;104(2):153-4. doi: 10.1097/SMJ.0b013e318205e575.

PMID:
21206410

Supplemental Content

Support Center